Search Results - "Vasilenko, A E"

Refine Results
  1. 1

    Successful use of the interleukin-17A inhibitor (ixekizumab) in the treatment of psoriatic arthritis by Dadalova, A. M., Vasilenko, E. A., Samigullina, R. R., Mazurov, V. I.

    Published in Sovremennai͡a︡ revmatologii͡a (25-11-2020)
    “…Psoriatic arthritis (PsA) is a chronic immune-mediated disease from a group of spondyloarthritis, which is characterized by damage to the musculoskeletal…”
    Get full text
    Journal Article
  2. 2

    Modification and application of metal phthalocyanines in heterogeneous systems by Perevalov, V. P., Vinokurov, E. G., Zuev, K. V., Vasilenko, E. A., Tsivadze, A. Yu

    “…This review discusses the main aspects of synthesis, structural modification, and practical application of an extremely important class of organic heterocyclic…”
    Get full text
    Journal Article
  3. 3

    Three-Domain Antibodies against the Tumor Necrosis Factor: Investigation of Their Biological Activity In Vitro by Vasilenko, E. A., Gorshkova, E. N., Astrakhantseva, I. V., Nedospasov, S. A., Mokhonov, V. V.

    Published in Russian journal of bioorganic chemistry (01-05-2020)
    “…— The aim of this work was to evaluate novel three-domain antibodies consisting of two domains specific for human tumor necrosis factor (hTNF), and of the…”
    Get full text
    Journal Article
  4. 4

    Bispecific Antibodies: Formats and Areas of Application by Vasilenko, E. A., Mokhonov, V. V., Gorshkova, E. N., Astrakhantseva, I. V.

    Published in Molecular biology (New York) (01-05-2018)
    “…Bispecific antibodies capable of simultaneously binding two targets have been studied for many years with a view to their implementation in clinical practice…”
    Get full text
    Journal Article
  5. 5
  6. 6

    A clinical case of adult-onset Still's disease resistant to therapy with tumor necrosis factor-alpha inhibitors and interleukin-6 inhibitors by Samigullina, R. R., Vasilenko, E. A., Mazurov, V. I.

    Published in Sovremennai͡a︡ revmatologii͡a (27-03-2019)
    “…The basis of the clinical picture of adult-onset Still's disease is a triad of symptoms, includingfever, arthralgia/arthritis, and characteristic rash called…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Anti-CD74 IGA antibodies, genetic polymorphisms and inflammatory activity in ankylosing spondylitis by Mazurov, V. I., Gaydukova, I. Z., Vasilenko, E. A., Vasilenko, E. A., Lapin, S. V., Lapin, S. V., Kholopova, I. V., Korolev, M. A.

    “…IgA anti-CD74 can be a promising marker for diagnosis, assessment of activity and prognosis for ankylosing spondylitis.The aim of the study was to determine…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Nail disease in psoriatic arthritis. Data from the Russian Psoriatic Arthritis Registry by Gubar, E. E., Korsakova, Y. L., Loginova, E. Yu, Korotaeva, T. V., Vasilenko, E. A., Vasilenko, A. A., Kuznetsova, N. A., Patkikeeva, I. M., Nasonov, E. L.

    “…Objective of the study – to compare, in real clinical practice, according to the data of the Russian Psoriatic Arthritis Registry, characteristics of two…”
    Get full text
    Journal Article
  11. 11

    The prevalence of comorbid and concomitant diseases in psoriatic arthritis patients, data from Russian register by Korsakova, Yu. L., Korotaeva, T. V., Loginova, E. Yu, Gubar, E. E., Vasilenko, E. A., Vasilenko, A. A., Kuznetsova, N. A., Patrikeeva, I. M., Nasonov, E. L.

    “…Psoriatic arthritis (PsA) is a heterogeneous inflammatory arthritis associated with psoriasis (Ps); it belongs to the group of spondyloarthritis and is…”
    Get full text
    Journal Article
  12. 12
  13. 13

    2017-2019 Sudden cardiac death registry of the Zabaykalsky Krai population (ZODIAC) by Zaitsev, D. N., Vasilenko, P. V., Govorin, A. V., Vasilenko, E. A., Mukha, N. V., Filev, A. P., Brizhko, A. N., Petrova, N. G., Sazonova, E. A.

    Published in Rossiĭskiĭ kardiologicheskiĭ zhurnal (05-12-2020)
    “…Aim . Based on the autopsy data, to analyze mortality patterns of the Zabaykalsky Krai population over a three-year period in the group of out-of-hospital…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Microbiota induces expression of tumor necrosis factor in postnatal mouse skin by Yuzhakova, D. V., Shirmanova, M. V., Bocharov, A. A., Astrakhantseva, I. V., Vasilenko, E. A., Gorshkova, E. N., Drutskaya, M. S., Zagaynova, E. V., Nedospasov, S. A., Kruglov, A. A.

    Published in Biochemistry (Moscow) (01-11-2016)
    “…Tumor necrosis factor (TNF) is a pleiotropic cytokine that regulates many important processes in the body. TNF production in a physiological state supports the…”
    Get full text
    Journal Article
  16. 16

    The clinical status and working capacity in patients included in the All-Russian Psoriatic Arthritis Registry by Loginova, E. Yu, Korotaeva, T. V., Korsakova, Yu. L., Gubar, E. E., Tremaskina, P. O., Vasilenko, E. A., Kushnir, I. N., Patkikeeva, I. M., Kudishina, S. S., Shesternya, P. A., Petrov, A. V., Kuznetsova, N. A., Nasonov, E. L.

    Published in Sovremennai͡a︡ revmatologii͡a (21-09-2020)
    “…Objective : to study the clinical characteristics of PsA and working capacity in patients included in the All-Russian PsA Registry. Patients and methods . The…”
    Get full text
    Journal Article
  17. 17

    System analysis of the efficiency and competitiveness of chroming technologies by Vinokurov, E. G., Meshalkin, V. P., Vasilenko, E. A., Nevmyatullina, Kh. A., Burukhina, T. F., Bondar’, V. V.

    “…The scientifically based selection of efficient chemical technologies is related to the integrated assessment of indicators of their energy and resource…”
    Get full text
    Journal Article
  18. 18

    Preparation of temozolomide-loaded polymer particles and study of their antitumor activity in models of glioma and melanoma by Nikolskaya, E. D., Zhunina, O. A., Vasilenko, E. A., Yabbarov, N. G., Tereshchenko, O. G., Sokol, M. B., Popenko, V. I., Severin, E. S.

    Published in Russian journal of bioorganic chemistry (01-09-2017)
    “…Temozolomide (TMZ) is a cytostatic drug used in treatment of patients with malignant gliomas and melanomas. The development of innovative formulations for…”
    Get full text
    Journal Article
  19. 19
  20. 20

    SINGLE DOMAIN ANTIBODIES AND BIOENGINEERING DRUGS ON THEIR BASIS: NEW OPPORTUNITIES FOR DIAGNOSTICS AND THERAPY by Gorshkova, E. N., Vasilenko, E. A., Tillib, S. V., Astrakhantseva, I. V.

    Published in Medit͡s︡inskai͡a︡ immunologii͡a (01-12-2016)
    “…Almost 20 years ago, a unique class of antibodies devoid of L chains was discovered in Camelidae blood serum. Only one variable domain is responsible for…”
    Get full text
    Journal Article